An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma.
Journal Information
Full Title: Acta Pharm Sin B
Abbreviation: Acta Pharm Sin B
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest The authors have no conflicts of interest to declare."
"This work was supported by the 10.13039/501100001809National Natural Science Foundation of China (No.81773911, 81690263, and 81573616), and the Development Project of Shanghai Peak Disciplines-Integrated Medicine (No.20180101). We thank Shengsheng Xie and the staff of the National Facility for Protein Science in Shanghai (NFPS) for valuable technical support. We sincerely thank Qiuyue Han and Yuqi Zhu for their great help with MRI imaging, Songlei Zhou and Yiwen Zhang for their guidance on the establishment of the recurrent GBM model, Yihui Deng and Huining He for their experience in immunotherapy, and Mengting Yang for the guidance on GBM cell culture."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025